Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.88
-0.37 (-1.41%)
At close: Oct 8, 2026, 4:00 PM EDT
25.88
0.00 (0.00%)
After-hours: Oct 8, 2026, 4:43 PM EDT
Maze Therapeutics Revenue
Maze Therapeutics had revenue of $20.00M in the twelve months ending June 30, 2026, up 700.00% year-over-year. That makes Maze Therapeutics the 33,795th largest company in the world by revenue and 4,453rd in the United States.
Revenue (ttm)
$20.00M
Revenue Growth
+700.00%
P/S Ratio
71.88
Revenue / Employee
$141,844
Employees
141
Market Cap
1.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
MAZE News
- 2 days ago - Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026 - GlobeNewsWire
- 15 days ago - Maze Therapeutics initiated with a Buy at Citi - TheFly
- 16 days ago - Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech - Barrons
- 23 days ago - Maze Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Maze Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 4 weeks ago - Maze Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 5 weeks ago - Maze Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 1 month ago - Maze Therapeutics Announces Appointments to Its Board of Directors - GlobeNewsWire